Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.

As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Two major UK cardiology trials are falling behind recruitment targets, prompting changes to entry criteria and calls for ...

Results from the Phase III CORALreef HeFH and CORALreef AddOn studies demonstrated tatistically significant and clinically ...

KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first ...